These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 39207780)
1. Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. Park S; Davis AM; Pillai AA JAMA; 2024 Sep; 332(12):1013-1014. PubMed ID: 39207780 [TBL] [Abstract][Full Text] [Related]
2. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology and management of hepatocellular carcinoma. Yang JD; Roberts LR Infect Dis Clin North Am; 2010 Dec; 24(4):899-919, viii. PubMed ID: 20937457 [TBL] [Abstract][Full Text] [Related]
4. Review article: the management of hepatocellular carcinoma. Cabrera R; Nelson DR Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500 [TBL] [Abstract][Full Text] [Related]
5. [New insights from the German guideline "hepatocellular carcinoma"]. Plentz RR; Malek NP; Dtsch Med Wochenschr; 2014 Dec; 139(49):2529-31. PubMed ID: 25423464 [No Abstract] [Full Text] [Related]
6. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort. Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of hepatitis C]. Thies P; Schmid RM; Geisler F MMW Fortschr Med; 2012 Nov; 154(19):59-62. PubMed ID: 23173289 [No Abstract] [Full Text] [Related]
9. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis]. Schott E; Bergk A; Berg T Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819 [TBL] [Abstract][Full Text] [Related]
10. Viral hepatitis and hepatocellular carcinoma. Marrero CR; Marrero JA Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352 [TBL] [Abstract][Full Text] [Related]
11. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma]. Pár A Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671 [TBL] [Abstract][Full Text] [Related]
12. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus infection in children. Komatsu H; Inui A Expert Rev Anti Infect Ther; 2015 Apr; 13(4):427-50. PubMed ID: 25724218 [TBL] [Abstract][Full Text] [Related]
15. The Changing Global Epidemiology of Hepatocellular Carcinoma. Caines A; Selim R; Salgia R Clin Liver Dis; 2020 Nov; 24(4):535-547. PubMed ID: 33012444 [TBL] [Abstract][Full Text] [Related]
16. Prognostic prediction in hepatocellular carcinoma: from art to science. Strazzabosco M; Cohen E; Emre S J Clin Gastroenterol; 2008 Mar; 42(3):221-3. PubMed ID: 18223506 [No Abstract] [Full Text] [Related]
17. British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010. Brook G; Main J; Nelson M; Bhagani S; Wilkins E; Leen C; Fisher M; Gilleece Y; Gilson R; Freedman A; Kulasegaram R; Agarwal K; Sabin C; Deacon-Adams C; HIV Med; 2010 Jan; 11(1):1-30. PubMed ID: 20059574 [No Abstract] [Full Text] [Related]
18. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323 [TBL] [Abstract][Full Text] [Related]
19. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study. Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK; Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118 [TBL] [Abstract][Full Text] [Related]